Evolva Holding SA (EVE.SW)

CHF 0.84

(-6.44%)

Revenue Summary of Evolva Holding SA

  • Evolva Holding SA's latest annual revenue in 2023 was 9.43 Million CHF , down -73.25% from previous year.
  • Evolva Holding SA's latest quarterly revenue in 2024 Q2 was - CHF , down 0.0% from previous quarter.
  • Evolva Holding SA reported a annual revenue of 15.53 Million CHF in annual revenue 2022, up 57.32% from previous year.
  • Evolva Holding SA reported a annual revenue of 9.87 Million CHF in annual revenue 2021, up 30.99% from previous year.
  • Evolva Holding SA reported a quarterly revenue of 4.45 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Evolva Holding SA reported a quarterly revenue of -295.9 Thousand CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Evolva Holding SA (2023 - 2005)

Historical Annual Revenue of Evolva Holding SA (2023 - 2005)

Year Revenue Revenue Growth
2023 9.43 Million CHF -73.25%
2022 15.53 Million CHF 57.32%
2021 9.87 Million CHF 30.99%
2020 7.54 Million CHF -34.97%
2019 11.59 Million CHF 29.82%
2018 8.93 Million CHF 30.47%
2017 6.84 Million CHF -28.5%
2016 9.57 Million CHF -28.34%
2015 13.36 Million CHF 24.38%
2014 10.74 Million CHF 23.41%
2013 8.7 Million CHF 24.12%
2012 7.01 Million CHF -36.69%
2011 11.08 Million CHF -40.52%
2010 18.62 Million CHF -1.58%
2009 18.92 Million CHF 4359.59%
2008 424.4 Thousand CHF 157.98%
2007 164.51 Thousand CHF -39.86%
2006 273.56 Thousand CHF 0.0%
2005 - CHF 0.0%

Peer Revenue Comparison of Evolva Holding SA

Name Revenue Revenue Difference
Addex Therapeutics Ltd 1.61 Million CHF -483.593%
BB Biotech AG -199.56 Million CHF 104.729%
Basilea Pharmaceutica AG 157.63 Million CHF 94.013%
Idorsia Ltd 152.38 Million CHF 93.807%
Kuros Biosciences AG 33.56 Million CHF 71.881%
Molecular Partners AG 7.03 Million CHF -34.098%
Relief Therapeutics Holding AG 6.03 Million CHF -56.436%
Santhera Pharmaceuticals Holding AG 103.41 Million CHF 90.874%